Trazodone is a potent agonist at 5-HT(2C) receptors mediating inhibition of the N-methyl-D-aspartate/nitric oxide/cyclic GMP pathway in rat cerebellum

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 3, 1998, Pages 983-986

  Marcoli, Manuela ^a   Maura, Guido ^a   Tortarolo, Massimo ^a   Raiteri, Maurizio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 PYRIDYL)UREA; CYCLIC GMP; KETANSERIN; MESULERGINE; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; RAUWOLSCINE; SEROTONIN 2C AGONIST; SPIPERONE; TRAZODONE;

ANIMAL TISSUE; ARTICLE; CEREBELLUM; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE;

ANIMALS; ANTI-ANXIETY AGENTS; CEREBELLUM; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; N-METHYLASPARTATE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; TRAZODONE;

EID: 0031862641     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 2C receptor protein in human and rat brain using specific antisera. Neuropharmacology 34:1635-1645.
2. 2 receptor subtypes: A family reunited? Trends Pharmacol Sci 16:105-110.
3. 1C receptors in drug-induced penile erections in rats. Psychopharmacology 101:57-61.
4. Boess FG and Martin IL (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33:275-317.
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
6. Brogden RN, Heel RC, Speight TM and Avery GS (1981) Trazodone: A review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs 21:401-429.
7. Bryant SG and Ereshefsky L (1982) Antidepressant properties of trazodone. Clin Pharmacol 1:406-417.
8. Caccia S, Ballabio M, Samanin R, Zanini MG and Garattini S (1981) mCPP, a central 5-HT agonist, is a metabolite of trazodone. J Pharm Pharmacol 33:477-478.
9. 2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP). Eur J Pharmacol 257:27-38.
10. Clineschmidt BV, Reiss DR, Pettibone DJ and Robinson JL (1985) Characterization of 5-hydroxytryptamine receptors in rat stomach fundus. J Pharmacol Exp Ther 235:696-708.
11. 1C receptor antagonist. J Med Chem 36:1104-1107.
12. Fuller RW, Snoddy HD and Cohen ML (1984) Interactions of trazodone with serotonin neurons and receptors. Neuropharmacology 23:539-544.
13. Garattini S, DeGaetano G, Samanin R, Bernasconi S and Roncaglioni MC (1976) Effects of trazodone on serotonin in the brain and platelets of the rat. Biochem Pharmacol 25:13-16.
14. Haria M, Fitton A and McTavish D (1994) Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging 4:331-355.
15. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR and Humphrey PPA (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-204.
16. 1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol 231:223-229.
17. Lou J-S, Goldfarb L, McShane L, Gatev P and Hallett M (1995) Use of buspirone for treatment of cerebellar ataxia. Arch Neurol 52:982-988.
18. 2C receptors. J Neurochem 69:427-430.
19. 2 presynaptic receptors mediate inhibition of glutamate release from cerebellar mossy fibre terminals. Eur J Pharmacol 202:185-190.
20. Maura G, Guadagnin A and Raiteri M (1995) Low nanomolar serotonin inhibits the glutamate receptor/nitric oxide/cyclic GMP pathway in slices from adult rat cerebellum. Neuroscience 68:455-463.
21. 1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro. J Neurochem 66:203-209.
22. 2C receptors mediate penile erections in rats: Actions of novel and selective agonists and antagonists. Eur J Pharmacol 325:9-12.
23. 2C receptors. Brain Res Mol Brain Res 23:163-178.
24. 1 receptors modulating transmitter release in rat cerebellum. J Pharmacol Exp Ther 237:644-648.
25. Sanders-Bush E and Breeding M (1990) Serotonin 1C receptor reserve in choroid plexus masks receptor supersensitivity. J Pharmacol Exp Ther 252:984-988.
26. 2C receptors. Eur J Pharmacol 296:307-318.
27. Smith TM and Suckow RF (1985) Trazodone and m-chlorophenylpiperazine. Concentration in brain and receptor activity in regions in the brain associated with anxiety. Neuropharmacology 24:1067-1071.
28. Stefanini E, Fadda F, Medda L and Gessa GL (1976) Selective inhibition of serotonin uptake by trazodone, a new antidepressant agent. Life Sci 18:1459-1465.
29. 2A receptor antagonistic activity. Eur J Pharmacol 329:27-35.
30. Trouillas P and Fuxe K (1993) Serotonin, The Cerebellum and Ataxia. Raven Press, New York.
31. Trouillas P, Xie J and Adeleine P (1996) Treatment of cerebellar ataxia with buspirone: A double-blind study. Lancet 348:759.
32. 1A sur l'ataxie cérébelleuse: une étude pilote. Rev Neurol (Paris) 151:708-713.
33. 2B receptor: Evidence for species differences. J Pharmacol Exp Ther 276:720-727.
34. Wrigglesworth SJ (1983) Heterogeneity of 5-hydroxytryptamine receptors in the rat uterus and stomach strip. Br J Pharmacol 80:691-697.
35. Wright DE, Seroogy KB, Lundgren KH, Davis BM and Jennes L (1995) Comparative localization of serotonin 1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comn Neurol 351:357-373.